Dr Reddys Laboratories (RDY) Other Operating Expenses (2009 - 2023)
Dr Reddys Laboratories (RDY) posted quarterly Other Operating Expenses of -$22.0 million for Q2 2023, down 144.44% on a QoQ basis from -$9.0 million in Q1 2023.
Dr Reddys Laboratories (RDY) Other Operating Expenses (2009 - 2023) Analysis & Trends
Dr Reddys Laboratories (RDY) has reported Other Operating Expenses for 13 consecutive years, with -$22.0 million the latest figure, recorded in Q2 2023.
- Quarterly Other Operating Expenses changed N/A year-over-year to -$22.0 million in Q2 2023, while the trailing twelve-month figure through Mar 2026 was -$22.0 million (up 29.03% YoY) and the FY2026 annual result came in at $81.0 million, up 58.82% from the prior year.
- Other Operating Expenses slipped to -$22.0 million in Q2 2023 per RDY's latest filing, from -$9.0 million in the prior quarter.
- Over the last five years, Other Operating Expenses for RDY reached as high as $9.0 in Q3 2022 and fell as low as -$53.0 million in Q1 2019.
- A 3-year average of -$14.1 million and a median of -$9.0 million in 2023 frame the typical range for Other Operating Expenses.
- The largest YoY upside for Other Operating Expenses was 0.0% in 2019 against a maximum downside of 1225.0% in 2019.
- Year by year, Other Operating Expenses stood at -$10.0 million in 2019, then surged by 70.0% to -$3.0 million in 2022, then slumped by 633.33% to -$22.0 million in 2023.
- According to Business Quant data, Other Operating Expenses over the past three periods registered -$22.0 million, -$9.0 million, and -$3.0 million for Q2 2023, Q1 2023, and Q4 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Dr Reddys Laboratories | 9.82 Bn | 9.66 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -22.00 Mn |
| Mar 31, 2023 | -9.00 Mn |
| Dec 31, 2022 | -3.00 Mn |
| Sep 30, 2022 | 9.00 |
| Sep 30, 2019 | -10.00 Mn |
| Jun 30, 2019 | -2.00 Mn |
| Mar 31, 2019 | -53.00 Mn |
| Dec 31, 2018 | -5.00 Mn |
| Sep 30, 2018 | -10.00 Mn |
| Mar 31, 2018 | -4.00 Mn |
| Dec 31, 2017 | -2.00 Mn |
| Sep 30, 2017 | -5.00 Mn |
| Dec 31, 2016 | -8.00 Mn |
| Mar 31, 2016 | -2.00 Mn |
| Dec 31, 2015 | -5.00 Mn |
| Sep 30, 2015 | -5.00 Mn |
| Jun 30, 2015 | -5.00 Mn |
| Dec 31, 2014 | -4.00 Mn |
| Dec 31, 2013 | -27.00 Mn |
| Dec 31, 2012 | 19.00 Mn |